AI will soon enable clinicians to predict ovulation and optimize IVF cycle timing, improving outcomes and operational efficiency....
Phase two collaboration aims to expand access to streamlined genomic workflows for infectious disease research...
Novel monoclonal antibody targets resolution of chronic inflammation through a differentiated therapeutic strategy...
Integrated automated platform unifies multi step sample preparation to improve consistency, reduce operational complexity, and enable high precision workflows across MRD testing and advanced molecular diagnostics...
Delivering results in 55 minutes - up to 6× faster than traditional colourimetric ELISAs...
The Breakthrough Device Designation is granted to medical technologies that have the potential to provide more effective treatment for life-threatening or irreversibly debilitating conditions...
Across Philips’ businesses, Dr Peron and her team provide medical leadership in areas including medical safety, medical affairs, health economics and outcomes research, clinical research ...
The company generated €5.4 million in revenue during the year and strengthened its financial position by raising €50.8 million in equity capital in October...
The Company also secured A$83 million in private placement funding to support growth initiatives, including European expansion....
Philips DeviceGuide uses AI to track and visualise mitral valve repair devices in real time during minimally invasive procedures, supporting treatment...
